Loud Spectrum Introduces Flower Derived Terpenes

SANTA ANA – Loud Spectrum, a terpene formulator, announced the launch of Flower Derived Terpenes (FDT). The first product, named Alive, is made only from Cannabis flower and extracted within an hour of harvest.

The company draws a line between FDT and what it calls Cannabis Derived Terpenes (CDT) typically pulled from whole-plant biomass, which includes stems and leaves. FDT leaves that material out. Loud Spectrum says custom equipment removes stem and leaf matter and limits terpene degradation and loss.

Co-founder and President Robin Christiansen described the timing pressure plainly. “It’s a race against the clock,” he said, adding that plants begin to oxidize and degrade once they are cut down. The company built its manufacturing system around that window, he noted.

Loud Spectrum (formerly Medical Terpenes) rebranded in November 2025. At the time, it wanted to apply terpenes to products beyond Cannabis, such as food, beverages, and home goods. The company developed the first strain-specific botanical terpene profiles and, in 2019, became one of the first to capture terpenes directly from fresh Cannabis flower.

Other suppliers are also working on aroma fidelity. True Terpenes introduced LOUD Flavors in July, a higher-intensity flavor platform it said responds to documented shifts in consumer preferences. In early February, the company released Headstash, which uses a full spectrum matrix to replace light volatiles lost in traditional processing.

Loud Spectrum’s entry targets manufacturers seeking native aromatics without the licensing hurdles tied to handling state-regulated whole-plant biomass. The company operates an extraction lab in Oregon alongside California facilities, subjecting the finished blends to third-party testing for residual solvents, heavy metals, and pesticides. Each batch receives an analytical certificate of analysis detailing purity levels.

The release includes profiles of popular strains like Jack Herer, Biscotti, Sour Diesel, Purple Punch, and GMO Cookies, among many others. Rather than blending isolated industrial molecules, the process relies on single-origin harvests sourced through contracted farm networks.

Wholesale adoption of flower-exclusive terpenes faces hurdles, chief among them production cost and agricultural variance. Botanically derived substitutes can be standardized at scale for pennies on the gram, while field-harvested inputs expose processors to crop fluctuations, seasonal yields, and higher shelf prices.

For brand owners watching margins compress, the decision to formulate with flower-derived terpenes comes down to retail consumer discernment. As consumers grow more attuned to artificial flavorings in vapes and infused pre-rolls, authentic flower extracts offer a tangible way to build premium product tiers. However, suppliers must demonstrate that the resulting sensory lift delivers enough register velocity to justify elevated input costs across mature retail channels.